Skip to main content
NIH funding notice PA-15-313

Research to Advance Vaccine Safety (R21)

Closed on July 24, 2018.

Posted
July 28, 2015
Close date
July 24, 2018
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $442,474 in first-year total cost, median $221,237.

Most frequent study sections

  1. Gene and Drug Delivery Systems Study Section[GDD]1
  2. Virology - B Study Section[VIRB]1

Most frequent institutions

  1. NORTH DAKOTA STATE UNIVERSITY1
  2. UNIVERSITY OF CONNECTICUT STORRS1
Competing awards under PA-15-313 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2018A Porcine Model for Torque Teno Virus Infections1R21AI137963-01RAMAMOORTHY, SHEELANORTH DAKOTA STATE UNIVERSITY, ND$223,176VIRB
2017Rapid development of replication-controlled vaccinia virus vectors for vaccines and therapeutics with single or double safety features1R21AI128737-01VERARDI, PAULO HUNIVERSITY OF CONNECTICUT STORRS, CT$219,298GDD

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.